| Philip C Moore, MD | |
|
805 Pamplico Hwy, Florence, SC 29505-6019 | |
| (843) 664-3301 | |
| (843) 664-3723 |
| Full Name | Philip C Moore |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 34 Years |
| Location | 805 Pamplico Hwy, Florence, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699793075 | NPI | - | NPPES |
| 277079 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 27707 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Heath Tuomey Hospital | Sumter, SC | Hospital |
| Spartanburg Medical Center | Spartanburg, SC | Hospital |
| Aiken Regional Medical Center | Aiken, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spartanburg Medical Center | 3072425297 | 843 |
| Ad Of South Carolina Llc | 6901269224 | 30 |
| Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.
Toy beads that were internationally recalled last year, after concerns that they may be coated with a dangerous chemical, are still being advertised on toy shop websites for purchase in the UK, warn doctors in this week's BMJ.
New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study "CHANGE-MS" (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
› Verified 5 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.
Toy beads that were internationally recalled last year, after concerns that they may be coated with a dangerous chemical, are still being advertised on toy shop websites for purchase in the UK, warn doctors in this week's BMJ.
New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study "CHANGE-MS" (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
› Verified 5 days ago
| Entity Name | Carolina Family Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184655722 PECOS PAC ID: 4587557731 Enrollment ID: O20040203000627 |
News Archive
Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.
Toy beads that were internationally recalled last year, after concerns that they may be coated with a dangerous chemical, are still being advertised on toy shop websites for purchase in the UK, warn doctors in this week's BMJ.
New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study "CHANGE-MS" (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
› Verified 5 days ago
| Entity Name | Spartanburg Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699729939 PECOS PAC ID: 3072425297 Enrollment ID: O20040702000686 |
News Archive
Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.
Toy beads that were internationally recalled last year, after concerns that they may be coated with a dangerous chemical, are still being advertised on toy shop websites for purchase in the UK, warn doctors in this week's BMJ.
New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study "CHANGE-MS" (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
› Verified 5 days ago
| Entity Name | York County Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487974606 PECOS PAC ID: 1850586355 Enrollment ID: O20101110000500 |
News Archive
Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.
Toy beads that were internationally recalled last year, after concerns that they may be coated with a dangerous chemical, are still being advertised on toy shop websites for purchase in the UK, warn doctors in this week's BMJ.
New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study "CHANGE-MS" (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
› Verified 5 days ago
| Entity Name | Medstream Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20140304001021 |
News Archive
Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.
Toy beads that were internationally recalled last year, after concerns that they may be coated with a dangerous chemical, are still being advertised on toy shop websites for purchase in the UK, warn doctors in this week's BMJ.
New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study "CHANGE-MS" (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
› Verified 5 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20210811002388 |
News Archive
Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.
Toy beads that were internationally recalled last year, after concerns that they may be coated with a dangerous chemical, are still being advertised on toy shop websites for purchase in the UK, warn doctors in this week's BMJ.
New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study "CHANGE-MS" (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
› Verified 5 days ago
| Entity Name | Ad Of South Carolina Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205518792 PECOS PAC ID: 6901269224 Enrollment ID: O20230901002506 |
News Archive
Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.
Toy beads that were internationally recalled last year, after concerns that they may be coated with a dangerous chemical, are still being advertised on toy shop websites for purchase in the UK, warn doctors in this week's BMJ.
New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study "CHANGE-MS" (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip C Moore, MD Po Box 198, Wichita, KS 67201-0198 Ph: (316) 685-6091 | Philip C Moore, MD 805 Pamplico Hwy, Florence, SC 29505-6019 Ph: (843) 664-3301 |
News Archive
Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.
Toy beads that were internationally recalled last year, after concerns that they may be coated with a dangerous chemical, are still being advertised on toy shop websites for purchase in the UK, warn doctors in this week's BMJ.
New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.
GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has initiated its planned Phase IIb study "CHANGE-MS" (Clinical trial assessing the HERV-W Env ANtagonist GNbAC1 for Efficacy in Multiple Sclerosis) with its lead antibody GNbAC1 in Relapsing-Remitting Multiple Sclerosis (RRMS).
› Verified 5 days ago
Dr. Robert M Savage, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 555 E Cheves St, Florence, SC 29506 Phone: 843-777-2000 | |
Dr. Paul Gregory Lee, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 506 E Cheves St Ste 202, Florence, SC 29506 Phone: 843-777-7000 Fax: 843-777-7005 | |
Martin F Evaldi, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 805 Pamplico Hwy, Florence, SC 29505 Phone: 843-664-3301 Fax: 843-664-3723 | |
Dr. David Grant Shy, D.O. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1430 S Cashua Dr, Florence, SC 29501 Phone: 843-665-9349 | |
Dr. Hans P Schlecht, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 555 E Cheves St, Florence, SC 29506 Phone: 843-661-6215 | |
Dr. Michael Darwin Wingfield, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 555 E Cheves St, Florence, SC 29506 Phone: 843-777-2000 | |
Bruce G Johnson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 E Cheves St Ste 480b, Florence, SC 29506 Phone: 843-432-1880 Fax: 843-432-1022 |